Kristen Rosati, a partner at Coppersmith Brockelman, shared her expertise in an article in Clinical Chemistry.  Kristen discussed the benefits of data warehouses and health information exchanges (HIEs), and the risks they can pose to patient privacy. She also provided insight into best practices in balancing patient privacy and the use of clinical data by having good data security and data governance processes.   Kristen advocated for a federal prohibition against reidentification of individuals in data used for research and quality improvement activities, which would address the acute need to use health information for research and at the same time honor individual rights.

Kristen has deep experience in data breaches, health information exchange, data sharing for research and clinical integration initiatives, clinical research compliance, clinical trials contracting, biobanking and genomic privacy, and all things “Big Data.” She is considered one of the nation’s leading HIPAA compliance attorneys, and is a sought-after national speaker and has been active in national healthcare policy.  Kristen was President of the American Health Lawyers Association in 2014-2014.

Read the full article here.